Liang, Yu-guang <br/><br/>
Pharmacokinetics and safety of a new bioengineered thrombolytic agent, human tissue urokinase type plasminogen activator in Chinese healthy volunteers.  [electronic resource] 

 -  European journal of drug metabolism and pharmacokinetics  Jan 2011 
 - 97-102 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0378-7966 
<br/><br/><label>Standard No.: </label>10.1007/s13318-010-0019-4  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Area Under Curve<br/>China<br/>Dose-Response Relationship, Drug<br/>Enzyme-Linked Immunosorbent Assay<br/>Female<br/>Fibrinolytic Agents--administration & dosage<br/>Half-Life<br/>Humans<br/>Injections, Intravenous<br/>Male<br/>Protein Engineering--methods<br/>Sex Factors<br/>Software<br/>Urokinase-Type Plasminogen Activator--administration & dosage<br/>Young Adult